Preliminary results of a phase I study of nivolumab (BMS-936558) in patients with relapsed or refractory lymphoid malignancies Meeting Abstract
| Authors: | Lesokhin, A. M.; Ansell, S. M.; Armand, P.; Scott, E. C.; Halwani, A.; Gutierrez, M.; Millenson, M. M.; Cohen, A. D.; Schuster, S. J.; Lebovic, D.; Dhodapkar, M. V.; Avigan, D.; Chapuy, B.; Ligon, A. H.; Rodig, S. J.; Cattry, D.; Zhu, L. L.; Grosso, J. F.; Kim, S. Y.; Shipp, M. A.; Borrello, I.; Timmerman, J. |
| Abstract Title: | Preliminary results of a phase I study of nivolumab (BMS-936558) in patients with relapsed or refractory lymphoid malignancies |
| Meeting Title: | 56th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 124 |
| Issue: | 21 |
| Meeting Dates: | 2014 Dec 6-9 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2014-12-06 |
| Language: | English |
| ACCESSION: | WOS:000349242706112 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V124.21.291.291 |
| Notes: | Meeting Abstract: 291 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
